reviews on glp 1 AltRx GLP-1 - Is It Worth Trying? What You Should Know Before Starting glp-1 review GLP-1 and the
Description
Access this article Similar content being viewed by others Data availability Data sharing does not apply to this article as no datasets were generated or analyzed during the current study

Patent Protection Creates Limited Market Competition Novo Nordisk holds the primary patents on semaglutide (Ozempic, Wegovy), while Eli Lilly controls tirzepatide (Zepbound, Mounjaro)

10.1080/00325481.2021.2002616 78 WolfeD.KanjiS.YazdiF.BarbeauP.RiceD.BeckA.et al (2020)

Am J Physiol Renal Physiol 315:F824F833

Vomiting, diarrhea and constipation occur less frequently but still affect notable numbers of patients
